Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

download Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

of 10

Transcript of Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    1/10

    Clemson UniversityInnovations

    From Idea to Impact

    Targeted ElastinRestoration Therapy

    Lisa Perpall MS [email protected]

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    2/10

    Clemson University Top 25 public university

    Legacy in bioengineering and

    biomaterials research

    Clemson University Research

    Foundation (CURF)

    Bridges research and industry

    Access to emerging technology Access to research resources

    Introduction

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    3/10

    Clemson Biomedical Research Resources

    Clemson, SC Basic Research Technology

    Development(BS, MS, PhD)

    Charleston, SCCU-MUSCBioengineering Alliance

    Clinical ResearchResearch Training

    Greenville, SC

    Translational ResearchFrom Bench to Bedside

    EducationIncubation

    http://www.biomaterials.org/index.cfmhttp://www.clemson.edu/agforestryresearch/gh/images/biosys_jpg.jpg
  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    4/10

    Featured Technology

    Targeted Elastin RestorationTherapy

    Clemson Inventors:Dr. Naren Vyavahare

    Aditi Sinha

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    5/10

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    6/10

    Invention

    Modified nanoparticles that target elastin fragments & deliver

    therapeutic agents to stabilize and regenerate elastin

    PEG-PLA nanoparticles with

    surface bound antibody

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    7/10

    Application Example: Aneurysm (AAA)

    Elastin degradation causesweakened vessel walls

    Abdominal Aortic Aneurysm

    (AAA)

    15,000 deaths per year1

    13thlargest cause of death1

    Agents to prevent or treat earlystage AAA

    Statins, anti-inflammatories,

    MMP inhibitors, etc.

    drug

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    8/10

    Nanoparticles injected into aneurysmal rats

    Calliper IVIS used for real time imaging of

    NPs in vivo

    The Science

    Elastin Targeting NP 24hControl PEG-PLA NP 24h

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    9/10

    The Science

    Targeted sustained drug delivery of agents for prevention,

    treatment, or regeneration MMP inhibitors

    Anti-inflammatories

    Elastin regeneration compounds (i.e. PGG)

    Elastin

    Targeting

    NPs 24h

    Aneurysmal aortaimaging @24 hrs

    ControlPEG-PLA

    NPs 24h

  • 8/13/2019 Presentation File 52dec1fd 3008 48d1 8cd3 07eeac10280a

    10/10

    (image from: www.beltina.org)

    Application OpportunitiesTopical, Respiratory, or Injection Delivery

    COPD

    3rdleading cause of death2

    2010 cost of COPD annually $49.9B

    2

    Treat/prevent loss of elastin in alveoli

    Skin CareCosmetic

    Anti-aging segment of facial skin care market$1.2B 20093

    Topical product for skin rejuvenation

    (www.celergenswiss.com)

    1- http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312219/#B4

    2- American Lung Association www.lung.org3- Frost and Sullivan 2011

    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312219/http://www.lung.org/http://www.lung.org/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312219/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312219/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312219/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312219/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312219/http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1312219/